Pacific Biosciences of California, Inc.

PACB Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of PACB by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
PACB Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
PACB Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
PACB Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in PACB holdings by institutional investors

Insider Trading

Quarterly net insider trading by PACB's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $60,000 Oct 20, 2022 Issue: Health Issues
  • $60,000 Oct 19, 2022 Issue: Health Issues
  • $60,000 Jul 20, 2022 Issue: Health Issues
  • $60,000 Jul 19, 2022 Issue: Health Issues
  • $60,000 Apr 20, 2022 Issue: Health Issues
  • $50,000 Apr 19, 2022 Issue: Health Issues
  • $50,000 Jan 20, 2022 Issue: Health Issues
  • $50,000 Jan 19, 2022 Issue: Health Issues
  • $50,000 Oct 20, 2021 Issue: Health Issues
  • $50,000 Oct 20, 2021 Issue: Health Issues
  • $20,000 Jul 20, 2021 Issue: Medicare/Medicaid
  • $20,000 Jul 20, 2021 Issue: Health Issues
Corporate Lobbying

PACB Estimated quarterly lobbying spending

Revenue Breakdown

PACB Revenue by Segment or Geography

By Segment
By Geography
PACB Income Statement
PACB Balance Sheet
PACB Cash Flow
U.S. Patents

New PACB patent grants

  • Patent Title: Heteroarylcyanine dyes with sulfonic acid substituents Apr. 19, 2016
  • Patent Title: Recombinant polymerases with increased phototolerance Mar. 29, 2016
  • Patent Title: Optics collection and detection system and method Mar. 22, 2016
  • Patent Title: Integrated analytical system and method Mar. 22, 2016
  • Patent Title: Targeted rolling circle amplification Mar. 22, 2016
  • Patent Title: Step-wise nucleic acid sequencing with catalytic and non-catalytic metals Mar. 08, 2016
  • Patent Title: Nanopores in zero mode waveguides Feb. 23, 2016
  • Patent Title: Methods and compositions for isolating template nucleic acids Feb. 23, 2016
  • Patent Title: Methods and compositions for sequencing modified nucleic acids Jan. 19, 2016
  • Patent Title: Illumination of optical analytical devices Dec. 29, 2015
  • Patent Title: Substrates, systems and methods for analyzing materials Dec. 29, 2015
  • Patent Title: Analytic devices comprising optical waveguides and nanometer-scale apertures and methods of uses thereof Dec. 29, 2015
  • Patent Title: Real-time sequencing methods and systems Dec. 01, 2015
  • Patent Title: Cis reactive oxygen quenchers integrated into linkers Dec. 01, 2015
  • Patent Title: Identification of 5-methyl-c in nucleic acid templates Nov. 03, 2015
  • Patent Title: Methods and processes for calling bases in sequence by incorporation methods Nov. 03, 2015
  • Patent Title: Methods for identifying nucleic acid modifications Nov. 03, 2015
  • Patent Title: Methods for identifying nucleic acid modifications Nov. 03, 2015
  • Patent Title: Sequence assembly and consensus sequence determination Oct. 20, 2015
  • Patent Title: Illumination of integrated analytical systems Oct. 13, 2015
  • Patent Title: Identifying modified bases using hemi-natural nucleic acids Oct. 06, 2015
  • Patent Title: Enzymes resistant to photodamage Sep. 08, 2015
  • Patent Title: Nanopore sequencing using n-mers Sep. 01, 2015
  • Patent Title: Modified base detection with nanopore sequencing Aug. 25, 2015
  • Patent Title: Integrated analytical system and method Jul. 07, 2015
  • Patent Title: Real-time analytical methods and systems Jun. 23, 2015
  • Patent Title: Polymerase enzyme substrates with protein shield Jun. 23, 2015
  • Patent Title: Intermittent detection during analytical reactions Jun. 16, 2015
  • Patent Title: Molecular redundant sequencing Jun. 09, 2015
  • Patent Title: Functionalized cyanine dyes (peg) Jun. 09, 2015
  • Patent Title: Field switch sequencing Jun. 02, 2015
  • Patent Title: Substrates, systems and methods for analyzing materials May. 12, 2015
  • Patent Title: Nanopore sequencing using ratiometric impedance Apr. 28, 2015
  • Patent Title: Recombinant polymerases for improved single molecule sequencing Apr. 07, 2015
  • Patent Title: Integrated analytical system and method Mar. 31, 2015
  • Patent Title: High multiplex arrays and systems Mar. 31, 2015
  • Patent Title: Nanopore sequencing using charge blockade labels Mar. 31, 2015
  • Patent Title: Asynchronous sequencing of biological polymers Mar. 31, 2015
  • Patent Title: Nanopore sequencing using charge blockade labels Mar. 24, 2015
  • Patent Title: Sequencing reactions with alkali metal cations for pulse width control Mar. 24, 2015
  • Patent Title: Nanopore sequencing devices and methods Mar. 24, 2015
  • Patent Title: System and methods for nucleic acid sequencing of single molecules by polymerase synthesis Mar. 17, 2015
  • Patent Title: Articles having localized molecules disposed thereon and methods of producing same Mar. 10, 2015
  • Patent Title: Methods and compositions for performing analytical operations Feb. 17, 2015
  • Patent Title: Real-time sequencing methods and systems Jan. 27, 2015
  • Patent Title: Active surface coupled polymerases Jan. 20, 2015
  • Patent Title: Purified extended polymerase/template complex for sequencing Jan. 20, 2015
  • Patent Title: Fret-labeled compounds and uses therefor Jan. 06, 2015
  • Patent Title: Nucleotide compositions and uses thereof Jan. 06, 2015
  • Patent Title: Phospholink nucleotides for sequencing applications Dec. 30, 2014
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to PACB from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
PACB News

Recent insights relating to PACB

CNBC Recommendations

Recent picks made for PACB stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PACB

PACB Analyst Ratings

PACB Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
PACB Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $PACB stock a Buy, Sell, or Hold?

  • What is the price target for $PACB stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

PACB Top Shareholders
Shareholder
Shares Held
PACB Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $PACB stock?

  • Who owns the most shares of $PACB stock?

  • What funds own $PACB stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

PACB Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view PACB Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About PACB

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

  • Address Menlo Park, CA
  • Market Cap 458.9 million
  • Employees 575
  • Industrial Classification Laboratory Analytical Instruments
Pacific Biosciences of California, Inc. Executive Compensation
Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation